Showing results (21-30 of 63) with videos related to

Sort By:
Pageof 7
Cancer Research|June 17, 2005
DNA-protein cross-links and replication-dependent histone H2AX phosphorylation induced by aminoflavone (NSC 686288), a novel anticancer agent active against human breast cancer cellsLing-hua Meng, Glenda Kohlhagen, Zhi-yong Liao, et al.
European Journal of Medicinal Chemistry|January 26, 2020
Design, synthesis, and biological evaluation of 1,2,5-oxadiazole-3-carboximidamide derivatives as novel indoleamine-2,3-dioxygenase 1 inhibitorsXiaohan Song, Pu Sun, Jiang Wang, et al.
Cancer Chemotherapy and Pharmacology|December 14, 2004
DNA damage, c-myc suppression and apoptosis induced by the novel topoisomerase II inhibitor, salvicine, in human breast cancer MCF-7 cellsHua-Rui Lu, Ling-Hua Meng, Min Huang, et al.
European Journal of Medicinal Chemistry|November 16, 2016
SAR study of 5-alkynyl substituted quinazolin-4(3H)-ones as phosphoinositide 3-kinase delta (PI3Kδ) inhibitorsManman Wei, Xi Zhang, Xiang Wang, et al.
Biochemical Pharmacology|February 7, 2012
Inhibition of tumor cell growth, proliferation and migration by X-387, a novel active-site inhibitor of mTORSi-meng Chen, Jia-li Liu, Xiang Wang, et al.
Medicinal Research Reviews|March 13, 2015
Targeting PI3Kδ: emerging therapy for chronic lymphocytic leukemia and beyondManman Wei, Xiang Wang, Zilan Song, et al.
The International Journal of Biochemistry & Cell Biology|April 5, 2008
ADAM15 suppresses cell motility by driving integrin alpha5beta1 cell surface expression via Erk inactivationQin Chen, Ling-Hua Meng, Cai-Hua Zhu, et al.
The Journal of Biological Chemistry|February 17, 2012
Inhibition of chemokine (CXC motif) ligand 12/chemokine (CXC motif) receptor 4 axis (CXCL12/CXCR4)-mediated cell migration by targeting mammalian target of rapamycin (mTOR) pathway in human gastric carcinoma cellsGuang Chen, Si-Meng Chen, Xiang Wang, et al.
Acta Pharmacologica Sinica|January 16, 2026
Targeting intrinsic and CAF-mediated signaling by PI3Kα inhibitor CYH33 attenuated metastasis in lung squamous cell carcinomaXiao-Yu Ma, Jie-Ting Deng, Zhe-Rui Cao, et al.
Acta Pharmacologica Sinica|January 19, 2018
The mTOR inhibitor AZD8055 overcomes tamoxifen resistance in breast cancer cells by down-regulating HSPB8Jia-Jie Shi, Si-Meng Chen, Chen-Liang Guo, et al.
Pageof 7